GLP-1 Advanced Weight Loss Program is a dual-action treatment that targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This unique mechanism helps regulate blood sugar levels while simultaneously supporting effective weight loss, making it a powerful option for metabolic health management.

Comprehensive, All-in-One Treatment Plan

This plan includes a flat-rate physician consultation and, if deemed appropriate by your provider, a single Tirzepatide prescription delivered to your door. Prescriptions are written at the physician’s discretion, based on the results of your telemedicine consultation. There is no guarantee—written or implied— of any specific prescription for any set duration. Cancellation requests can be submitted through your secure account portal.

Access to Leading Weight Loss Medications

Astra prescribes proven weight loss medications such as Ozempic®, Wegovy®, and Zepbound®—some of the most effective options available today.

Your membership includes:
✔ A provider consultation & prescription (if appropriate)
✔ Access to GLP-1 medications
✔ Ongoing care & support to help you stay on track

Important Notice

† Ozempic®, WeGovy®, Saxenda®, and Victoza® are registered trademarks of Novo Nordisk. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly. Amble Health is not affiliated with Novo Nordisk or Eli Lilly.

Compounded medications may be prescribed when medically necessary. While federal law permits the prescription of compounded drugs, they are not FDA-approved and do not undergo the same safety, effectiveness, or manufacturing review as commercially available medications.

For Important Safety Information Regarding GLP-1 Advanced Weight Loss Program - click here.